ArticleThe British journal of dermatology2024

Correction to: Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.